TRANSFUSION AND APHERESIS SCIENCE, cilt.54, sa.3, ss.410-415, 2016 (SCI-Expanded)
Objectives and Aim: In this study, we aimed to compare the potency of different G-CSF agents including original filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) on CD34(+) cell mobilization in patients that underwent allogeneic hematopoietic stem cell transplantation (alloHSCT).